CR20140570A - Composición para higiene íntima extendida, proceso de producción y uso - Google Patents

Composición para higiene íntima extendida, proceso de producción y uso

Info

Publication number
CR20140570A
CR20140570A CR20140570A CR20140570A CR20140570A CR 20140570 A CR20140570 A CR 20140570A CR 20140570 A CR20140570 A CR 20140570A CR 20140570 A CR20140570 A CR 20140570A CR 20140570 A CR20140570 A CR 20140570A
Authority
CR
Costa Rica
Prior art keywords
composition
production
use process
intimate hygiene
extended
Prior art date
Application number
CR20140570A
Other languages
English (en)
Spanish (es)
Inventor
Rodrigues Guimarães Priscila Ramos
Original Assignee
Sanofi Aventis Farmacêutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Farmacêutica Ltda filed Critical Sanofi Aventis Farmacêutica Ltda
Publication of CR20140570A publication Critical patent/CR20140570A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986Milk; Derivatives thereof, e.g. butter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CR20140570A 2012-07-16 2014-12-11 Composición para higiene íntima extendida, proceso de producción y uso CR20140570A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102012017571-1A BR102012017571A2 (pt) 2012-07-16 2012-07-16 Composição para higiene íntima prolongada, processo de produção e uso
PCT/BR2013/000088 WO2014012156A1 (pt) 2012-07-16 2013-03-22 Composição para higiene íntima prolongada, processo de produção e uso

Publications (1)

Publication Number Publication Date
CR20140570A true CR20140570A (es) 2015-02-04

Family

ID=49948122

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140570A CR20140570A (es) 2012-07-16 2014-12-11 Composición para higiene íntima extendida, proceso de producción y uso

Country Status (12)

Country Link
AR (1) AR091330A1 (pt)
BR (1) BR102012017571A2 (pt)
CL (1) CL2015000101A1 (pt)
CO (1) CO7160048A2 (pt)
CR (1) CR20140570A (pt)
DO (1) DOP2014000276A (pt)
EC (1) ECSP15001584A (pt)
GT (1) GT201500008A (pt)
MX (1) MX2014014896A (pt)
PE (1) PE20150768A1 (pt)
UY (1) UY34910A (pt)
WO (1) WO2014012156A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002113041A (ja) * 2000-10-11 2002-04-16 Uni Charm Corp 皮膚常在菌をコントロールする吸収性物品
BRPI0800156A2 (pt) * 2008-02-20 2009-12-29 Cruz Luis Eduardo Da kit de sabonetes para higiene ìntima feminina e composição de sabonete para uso durante o perìodo menstrual
FR2933617B1 (fr) * 2008-07-10 2010-09-17 Alliospharma Compositions visant a favoriser le developpement et la croissance d'une microflore vaginale benefique
IT1393777B1 (it) * 2009-04-03 2012-05-08 Rottapharm Spa Composizione per l'igiene intima
EP2248907A1 (en) * 2009-05-08 2010-11-10 Rijksuniversiteit Groningen Gluco-oligosaccharides comprising (alpha 1-->4) and (alpha 1-->6) glycosidic bonds, use thereof, and methods for providing them

Also Published As

Publication number Publication date
CO7160048A2 (es) 2015-01-15
CL2015000101A1 (es) 2015-06-26
DOP2014000276A (es) 2015-03-15
WO2014012156A1 (pt) 2014-01-23
UY34910A (es) 2014-02-28
PE20150768A1 (es) 2015-05-23
GT201500008A (es) 2017-10-09
AR091330A1 (es) 2015-01-28
ECSP15001584A (es) 2015-09-30
MX2014014896A (es) 2015-03-05
BR102012017571A2 (pt) 2014-06-10

Similar Documents

Publication Publication Date Title
CO6771447A2 (es) Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
ECSP14013284A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
UY33396A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
HN2011002037A (es) Dicianopiridinas alquilamino-sustituidas y sus profarmacos de ester de aminoacido
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
EA201691032A1 (ru) Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
BR112015029462A2 (pt) Inibidores de quinase
GT201400050A (es) Derivados de anilina, su preparación y su aplicación terapéutica
BR112017011476A2 (pt) composição baseada em aminoácidos para recuperação de fibroelastina em tecidos conjuntivos dérmicos e uso
BR112013010136A2 (pt) vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
AR100365A1 (es) Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
CL2018001719A1 (es) Tratamiento contra el mieloma múltiple (divisional solicitud 201600396)
ECSP13012603A (es) Nueva formulacion del cetp(1)
EA201490041A1 (ru) Пластырь, содержащий диклофенак и тиоколхикозид
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
MX2018004296A (es) Combinacion de un agonista selectivo de il-2rbeta y un agonista il-15 de accion prolongada.
ECSP15050273A (es) Formulación oral para el tratamiento de enfermedades cardiovasculares
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
CR20140570A (es) Composición para higiene íntima extendida, proceso de producción y uso